D
40
2
KO
38
-3
GILD
47
-8
WBA
43
-4
THC
60
-5
SWKS
38
-2
ZTS
47
2
FFIV
66
-4
BK
74
3
UNH
57
-2
URI
60
-6
WYNN
36
-5
EIX
70
3
O
17
-13
FITB
60
-5
ADSK
66
-4
WMB
68
2
TGT
45
-4
CVX
43
-3
PDCO
29
2
D
40
2
KO
38
-3
GILD
47
-8
WBA
43
-4
THC
60
-5
SWKS
38
-2
ZTS
47
2
FFIV
66
-4
BK
74
3
UNH
57
-2
URI
60
-6
WYNN
36
-5
EIX
70
3
O
17
-13
FITB
60
-5
ADSK
66
-4
WMB
68
2
TGT
45
-4
CVX
43
-3
PDCO
29
2
Financhill
Back

Galmed Pharmaceuticals 10K Form

Sell
7

GLMD
Galmed Pharmaceuticals

Last Price:
2.90
Seasonality Move:
13.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GLMD News And Ratings

See the #1 stock for the next 7 days that we like better than GLMD

GLMD Financial Statistics

Sales & Book Value

Annual Sales: $2.04M
Cash Flow: $-1.02M
Price / Cash Flow: 0
Annual Sales: $22.24
Price / Book: 0.16

Profitability

EPS (TTM): -19.56000
Net Income (TTM): $-5.88M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Galmed Pharmaceuticals Earnings Forecast

Key Galmed Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLMD is 0.00%.
  • The Selling, General & Administrative Expenses for GLMD have been equal to 217.86% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Galmed Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLMD
CUSIP: M47238
Website: galmedpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLMD Technical Analysis vs Fundamental Analysis

Sell
7
Galmed Pharmaceuticals (GLMD) is a Sell

Is Galmed Pharmaceuticals a Buy or a Sell?